We have talked about the potential of partial cellular reprogramming in previous articles, and today, we want to...

As mentioned in some recent articles, we are increasing our efforts to reward our loyal and invaluable monthly p...

Last year, resTORbio announced the positive results of its phase 2b human trial, which targeted the aging immune...

We recently visited the Longevity Leaders Conference in London and had the opportunity to speak with Kelsey Mood...

On Monday, April 8th, we will be hosting our second Lifespan.io webinar, during which we will be discussing the ...

The March Journal Club hosted by Dr. Oliver Medvedik will focus on this recent study that showed transplanting t...